Venous Thromboembolism (VTE)
36
11
12
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 36 trials
100.0%
+13.5% vs benchmark
39%
14 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (36)
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
3D-EIT for Diagnosis and Monitoring of Pulmonary Embolism
Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Design and Rationale of the COLT Study
Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
Duke Virtual IntEgrated Workflow
Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin
Delivery and Implementation of a Randomised Crossover Trial on Thrombosis
External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention
Informative Video Before LMWH Postpartum - Randomized Controlled Trial
Heat Shock Protein 47 in Thrombosis
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on Dialysis